Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

This is a Post Market, Multi-center, Open Label, Observational Study. Approximately 500 Subjects With Uncontrolled Hypertension Will Undergo Renal Artery Ablation

NCT01996033 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01996033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01996033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
This is a Post Market, Multi-center, Open Label, Observational Study. Approximately 500 Subjects With Uncontrolled Hypertension Will Undergo Renal Artery Ablation
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
January 31, 2017
Enrollment
25 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

uncontrolled hypertension